Woodline Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Woodline Partners's ZBH Position: Q2 2026 in Review
Woodline Partners increased its Zimmer Biomet (ZBH) stake by 1,186% in Q2 2026, buying an estimated $76.2M and bringing the position to 942,300 shares worth $81.1M. The position accounts for 0.25% of the portfolio, ranked #98.
Woodline Partners first reported a position in ZBH in Q4 2019 and has held it in 25 quarters since. The position peaked at $121M in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Woodline Partners held 942,300 shares of Zimmer Biomet worth $81.1M as of Q2 2026.
- Woodline Partners bought 869,014 Zimmer Biomet shares in Q2 2026, an estimated $76.2M.
- Zimmer Biomet made up 0.25% of Woodline Partners's portfolio in Q2 2026, its #98 holding.
- Woodline Partners first reported a position in Zimmer Biomet in Q4 2019 and has held it in 25 quarters since.
- Woodline Partners's Zimmer Biomet position peaked at $121M in Q1 2024.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.